Neudopa Plus is a combination of levodopa, carbidopa and entacapone for the treatment of Parkinson’s disease.
Neudopa Plus (Levodopa + Carbidopa + Entacapone) is indicated for the treatment of Parkinson’s disease .
To substitute Entacapone) can be used:(with equivalent strengths of each of the three components)
To replace carbidopa/levodopa therapy (without entacapone) when patients experience the signs and symptoms of end-of-dose “wearing-off” and when they have been taking a total daily dose of levodopa of 600mg or less and have no t been experiencing dyskinesias .
Explore more products from our portfolio
